Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Related Citations for PubMed (Select 24565013)

1.

Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery.

Nathan PJ, Phan KL, Harmer CJ, Mehta MA, Bullmore ET.

Curr Opin Pharmacol. 2014 Feb;14:54-61. doi: 10.1016/j.coph.2013.11.009. Epub 2013 Dec 8. Review.

PMID:
24565013
2.

Use of non-invasive neuroradiological methods in research of psychoactive drugs.

Henigsberg N, Kovacić Z, Kalember P.

Psychiatr Danub. 2007 Sep;19(3):234-7.

PMID:
17914326
3.

The role of imaging in proof of concept for CNS drug discovery and development.

Wong DF, Tauscher J, Gründer G.

Neuropsychopharmacology. 2009 Jan;34(1):187-203. doi: 10.1038/npp.2008.166. Epub 2008 Oct 8. Review.

4.

Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics.

Bifone A, Gozzi A.

Expert Opin Drug Discov. 2012 Nov;7(11):1071-82. doi: 10.1517/17460441.2012.724057. Epub 2012 Sep 13. Review.

PMID:
22971143
5.

Use of functional imaging across clinical phases in CNS drug development.

Borsook D, Becerra L, Fava M.

Transl Psychiatry. 2013 Jul 16;3:e282. doi: 10.1038/tp.2013.43.

6.

The role of fMRI in drug discovery.

Wise RG, Tracey I.

J Magn Reson Imaging. 2006 Jun;23(6):862-76. Review.

PMID:
16649197
7.

What is the value of human FMRI in CNS drug development?

Wise RG, Preston C.

Drug Discov Today. 2010 Nov;15(21-22):973-80. doi: 10.1016/j.drudis.2010.08.016. Epub 2010 Sep 15. Review.

PMID:
20813202
8.

Role of functional magnetic resonance imaging in drug discovery.

Paulus MP, Stein MB.

Neuropsychol Rev. 2007 Jun;17(2):179-88. Epub 2007 Apr 10. Review.

9.

Using NMR approaches to drive the search for new CNS therapeutics.

Borsook D, Becerra L.

Curr Opin Investig Drugs. 2010 Jul;11(7):771-8. Review.

10.

Exploratory translational modeling approach in drug development to predict human brain pharmacokinetics and pharmacologically relevant clinical doses.

Kielbasa W, Stratford RE Jr.

Drug Metab Dispos. 2012 May;40(5):877-83. doi: 10.1124/dmd.111.043554. Epub 2012 Jan 27.

11.

Drug discovery in psychiatric illness: mining for gold.

Elmer GI, Kafkafi N.

Schizophr Bull. 2009 Mar;35(2):287-92. doi: 10.1093/schbul/sbn194. Epub 2009 Mar 18.

12.

Applications of functional magnetic resonance imaging in psychiatry.

Mitterschiffthaler MT, Ettinger U, Mehta MA, Mataix-Cols D, Williams SC.

J Magn Reson Imaging. 2006 Jun;23(6):851-61. Review.

PMID:
16652410
13.

Applications of imaging biomarkers in the early clinical development of central nervous system therapeutic agents.

Cole PE, Schwarz AJ, Schmidt ME.

Clin Pharmacol Ther. 2012 Feb;91(2):315-20. doi: 10.1038/clpt.2011.286. Epub 2012 Jan 4. Review.

PMID:
22218072
14.

A role for fMRI in optimizing CNS drug development.

Borsook D, Becerra L, Hargreaves R.

Nat Rev Drug Discov. 2006 May;5(5):411-24. Review.

PMID:
16604100
15.

Neuroimaging-based biomarkers in psychiatry: clinical opportunities of a paradigm shift.

Fu CH, Costafreda SG.

Can J Psychiatry. 2013 Sep;58(9):499-508. Review.

PMID:
24099497
16.

Neuropsychiatric dynamics: the study of mental illness using functional magnetic resonance imaging.

Callicott JH, Weinberger DR.

Eur J Radiol. 1999 May;30(2):95-104. Review.

PMID:
10401590
17.

[Contribute of functional magnetic resonance imaging to the understanding of psychiatric disorders].

Höller Y, Kronbichler M, Zeller A, Klein S, Hinterhuber H, Golaszewski S, Ladurner G.

Neuropsychiatr. 2009;23(2):84-90. Review. German.

PMID:
19573501
18.

Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders?

Hertz L, Chen Y, Gibbs ME, Zang P, Peng L.

Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):239-67. Review.

PMID:
15180484
19.

Innovative solutions to novel drug development in mental health.

Insel TR, Voon V, Nye JS, Brown VJ, Altevogt BM, Bullmore ET, Goodwin GM, Howard RJ, Kupfer DJ, Malloch G, Marston HM, Nutt DJ, Robbins TW, Stahl SM, Tricklebank MD, Williams JH, Sahakian BJ.

Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 1):2438-44. doi: 10.1016/j.neubiorev.2013.03.022. Epub 2013 Apr 3. Review.

20.

Modern neuroimaging in psychiatry: towards the integration of functional and molecular information.

Linden D, Thome J.

World J Biol Psychiatry. 2011 Sep;12 Suppl 1:6-10. doi: 10.3109/15622975.2011.598713. Review.

PMID:
21905987
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk